Zhejiang University

This study tests if a newer, less extensive surgery (LISH) can work as well as the standard surgery for cancers in the right part of the colon. About 568 adults with colon cancer that hasn't spread will be randomly assigned to one of the two surgeries. The main goal is to see if …

This study tests a treatment called CD19 CAR-T therapy for people newly diagnosed with a fast-growing type of blood cancer called high-risk large B-cell lymphoma. The therapy uses a patient's own immune cells, which are modified in a lab to better find and attack cancer cells. Th…

This early study tests a new treatment for people with advanced liver cancer that has not responded to standard therapies. The treatment uses the patient's own immune cells, which are modified in a lab to recognize and attack cancer cells. The main goals are to check the safety o…

This study tests whether combining two targeted drugs (cetuximab beta and fruquintinib) with or without immunotherapy can control advanced colorectal cancer without chemotherapy. About 70 people with a specific genetic type (RAS/BRAF wild-type) will receive the treatment as their…

This study tests whether a high-flow nasal cannula (a special oxygen delivery device) can prevent low oxygen levels during sedated endoscopy in people at high risk for obstructive sleep apnea. About 600 adults with a high STOP-Bang score (indicating sleep apnea risk) will be rand…

This study tests a new device called the COMBO Endoscopy Oropharyngeal Airway in 580 obese patients undergoing sedated gastrointestinal endoscopy. The device combines oxygen support, airway management, and monitoring to prevent low oxygen levels (hypoxia), a common risk in these …